# Enanta Pharmaceuticals Inc: Form DEF 14A, filed Jan 26, 2024

- Company: [Enanta Pharmaceuticals Inc](/companies/enta.md) (CIK 1177648)
- Form: DEF 14A
- Filed: 2024-01-26
- Accepted by EDGAR: Jan 26, 2024, 16:25 ET
- Period: 2024-03-06
- Accession: 0000950170-24-007956
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1177648/000095017024007956/enta-20240126.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1177648/000095017024007956/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1177648/000095017024007956/enta-20240126.htm

Filed Jan 26, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-007956. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.